Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PeriGen (formerly E&C Medical Intelligence) is a healthcare technology company that provides advanced clinical decision support and risk management solutions for obstetrics. The company's flagship platform, PeriWatch, utilizes artificial intelligence and automated early warning systems to monitor fetal heart rate, maternal vital signs, and labor progress in real-time. These tools are designed to alert clinicians to potential complications during childbirth, thereby improving patient safety and reducing maternal and neonatal morbidity. PeriGen's solutions are used in hundreds of healthcare facilities across North America, ranging from academic medical centers to rural hospitals. In 2021, the company was acquired by Halma plc for $58 million and now operates as a standalone business within Halma's medical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on E&C Medical Intelligence.